Abnormal cholesterol biosynthesis in sitosterolaemia and the Smith-Lemli-Opitz syndrome

Journal of Inherited Metabolic Disease

Volumn 19, Issue 4, 1996, Pages 391-400

  Salen, G ^a,b   Shefer, S ^a,b   Batta, A K ^a,b   Tint, G S ^a,b   Xu, G ^a,b   Honda, A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 DEHYDROCHOLESTEROL; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MESSENGER RNA; PHYTOSTEROL; STEROL;

ADOLESCENT; ADULT; CELL GROWTH; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONFERENCE PAPER; CONGENITAL MALFORMATION; CONTROLLED STUDY; DISORDERS OF CHOLESTEROL METABOLISM; ENZYME ACTIVITY; ENZYME DEFECT; FACE DYSMORPHIA; FIBROBLAST; HOMOZYGOTE; HUMAN; INTESTINE ABSORPTION; LIVER MICROSOME; MAJOR CLINICAL STUDY; MENTAL DEFICIENCY; PHENOTYPE; SMITH LEMLI OPITZ SYNDROME; TISSUE LEVEL;

ANIMALS; CHOLESTEROL; HUMANS; OXIDOREDUCTASES; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; RATS; SITOSTEROLS; SMITH-LEMLI-OPITZ SYNDROME;

EID: 0029785460     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf01799100     Document Type: Article

References (25)

1. Batta AK, Tint GS, Abuelo D, Shefer S, Salen G (1995a) Identification of 8-dehydrocholesterol (cholesta-5,8-dien-3β-ol) in patients with the Smith-Lemli-Opitz syndrome. J Lipid Res 36: 705-713.
2. Batta A, Salen G, Tint GS, Shefer S (1995b) Identification of 19-nor-5,7,9(10)cholestatrien-3β-ol in the Smith-Lemli-Opitz syndrome. J Lipid Res 36: 2413-2418.
3. Bhattacharyya A, Connor WE (1974) β-Sitosterolemia and xantomatosis. A new described lipid storage disease in two sisters. J Clin Invest 53: 1033-1043.
4. Bhattacharyya AK, Connor WE (1991) Sluggish sitosterol turnover and hepatic failure to excrete sitosterol into bile cause expansion of the body pool of sitosterol in patients with sitosterolemia and xanthomatosis. Atheroscler Thromb 11: 1287-1294.
5. 7-reductase activities in rats: effect of BM 15.766, cholesterol, cholic acid, and lathosterol. Unpublished observations.
6. Irons M, Elias ER, Salen G, Tint GS, Batta AK (1993) Defective cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome. Lancet 341: 1414.
7. Miettinen TA (1980) Phytosterolemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis. Eur J Clin Invest 10: 27-35.
8. Nguyen L, Shefer S, Salen G, et al (1990a) Molecular defect in cholesterol synthesis in sitosterolemia with xanthomatosis. J Clin Invest 86: 926-931.
9. Nguyen L, Salen G, Shefer S, Shore V (1990b) Unexpected failure of bile acid malabsorption to stimulate cholesterol synthesis in sitosterolemia with xanthomatosis: comparison with lovastatin. Arteriosclerosis 10: 289-297.
10. Opitz JM, De La Cruz F (1994) RSH/SLO ('Smith-Lemli-Opitz') syndrome: historical, genetic, and developmental considerations. Am J Med Genet 50: 344-346.
11. Salen G, Shefer S, Berginer V (1983) Familial diseases with storage of sterols other than cholesterol. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The Metabolic Basis of Inherited Disease, 5th edn. New York: McGraw-Hill, 713-730.
12. Salen G, Kwiterovich Jr PO, Shefer S, et al (1985a) Increased plasma eholestanol and 5α-saturated plant sterol derivative in subjects with sitosterolemia and xanthomatosis. J Lipid Res 26: 203-209.
13. Salen G, Horak I, Rothkopf M, et al (1985b) Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis. J Lipid Res 216: 1126-1133.
14. Salen G, Shore V, Tint GS, et al (1989) Increased sitosterolemia absorption, decreased removal, and expanded body pools compensate for reduced cholesterol synthesis in sitosterolemia with xanthomatosis. J Lipid Res 30: 1319-1330.
15. Salen G, Shefer S, Nguyen L, Ness GC, Tint GS, Shore V (1992) Sitosterolemia. J Lipid Res 33: 945-955.
16. Salen G, Batta AK, Tint GS, Shefer S, Ness GC. Inverse relationship between plasma eholestanol concentrations and bile acid synthesis in sitosterolemia. J Lipid Res 35: 1878-1887.
17. Salen G, Shefer S, Batta AK, Tint GS (1995) Biochemical abnormalities in the Smith-Lemli-Opitz syndrome. Int Pediatr 10: 33-36.
18. Shefer S, Salen G, Nguyen L, et al (1988) Competitive inhibition of bile acid synthesis by eholestanol and sitosterol in sitosterolemia with xanthomatosis. J Clin Invest 82: 1833-1839.
19. Shefer S, Salen G, Bullock J, et al (1994) The effect of increased hepatic sitosterol on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and cholesterol 7α-hydroxylase in the rat and sitosterolemia homozygotes. Hepatology 20: 203-214.
20. 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes. J Clin Invest 96: 1779-1785.
21. Smith DW, Lemli L, Opitz J (1964) A newly recognized syndrome of multiple congenital anomalies. J Pediatr 64: 210-217.
22. Tint GS, Irons M, Elias ER, et al (1994) Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 330: 107-113.
23. Tint GS, Salen G, Batta AK, et al (1995) Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome. J Pediatr 127: 92-97.
24. Xu G, Salen G, Shefer S, et al (1995a) Reproducing the abnormal cholesterol biosynthesis as seen in Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats. J Clin Invest 95: 76-81.
25. Xu G, Salen G, Shefer S, et al (1995b) Treatment of the cholesterol biosynthetic defect in Smith-Lemli-Opitz syndrome reproduced in rats by BM 15,766. Gastroenterology 109: 1301-1307.